Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jeannie T. Lee
Thomas Jefferson University, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Massachusetts General Hospital
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Lee is a co-founder of Translate Bio. She owns equity in the privately held company and receives compensation for serving on the company’s Scientific Advisory Board. Translate Bio is focused on developing therapeutics that selectively activate RNA through the regulation of lncRNA, and the research grant focuses on understanding the mechanisms of lncRNA and RNA regulation. Therefore, the institution determined that the interests of the company could be affected by the research. The institution further determined that, based on the magnitude of the financial interest and the close connection between the company's interests and the research, the financial interest could directly and significantly affect the design, conduct, or reporting of the research.
Molecular and biological function of long non-coding RNA transcripts divergent to lung development genes
Advanced technologies to sequence all RNAs expressed in mammalian cells have allowed scientists to discover that more than 90% of the genome is transcribed into RNA, despite that only 2-3% is the fraction of RNA that is translated into proteins. Long-non-coding RNAs (-longer than 200 nucleotides) represent a large fraction of the transcribed genome, do not code for proteins and function as RNA in regulating gene expression. We plan to study two long non-coding RNAs relevant to lung development and disease using human and mouse induced pluripotent stem cell lines differentiating into lung epithelial cells with the goal to uncover new mechanisms of lung gene regulation leading to a greater understanding of lung development and diseases, and to new ways of disease detection and treatment.
Filed on November 01, 2017.
Tell us what you know about Jeannie T. Lee's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Jeannie T. Lee”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jeannie T. Lee | Massachusetts General Hospital | Conflict of Interest | RaNA Therapeutics | Value cannot be readily determined |
| Jeannie T. Lee | Massachusetts General Hospital | Conflict of Interest | RaNA Therapeutics | $40,000 - $59,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.